New drugs for rheumatoid arthritis [6] (multiple letters)

New England Journal of Medicine

Volumn 351, Issue 25, 2004, Pages 2659-2661

  Roberts, Lynden J ^a   Kalil, Andre C ^b   Messori, Andrea ^c   Santarlasci, Benedetta ^c   Vaiani, Monica ^c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^c Laboratorio SIFO di Farmacoeconomia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR ALPHA;

ANAMNESIS; CLINICAL TRIAL; HUMAN; JOINT DESTRUCTION; LETTER; META ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RHEUMATOID ARTHRITIS; STATISTICS; DRUG ANTAGONISM; DRUG COMBINATION; NOTE; STATISTICAL ANALYSIS; CONTROLLED CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DATA INTERPRETATION, STATISTICAL; DRUG THERAPY, COMBINATION; HUMANS; META-ANALYSIS; METHOTREXATE; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA; RANDOMIZED CONTROLLED TRIALS;

EID: 13644273999     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200412163512522     Document Type: Letter

References (0)